Australia's most trusted
source of pharma news
Saturday, 14 December 2024
Posted 3 April 2024 AM
Seven drugs have been added to the PBS this month, including Novartis' long-awaited blockbuster hopeful Leqvio.
Leqvio is the first siRNA therapy to lower LDL-C or 'bad cholesterol' in the bloodstream and only requires two doses a year, after an initial dose and one at three months.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.